4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-009168
Chief Financial Officer sold 32,500 shares at an average $31.89 ($1,036,459)
- Chief Financial Officer acquired 21,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2023-03-16 | Sale | −30,796 | $31.86 | $981,139 | 3,213 | D |
| FRATES JAMES M Chief Financial Officer | 2023-03-16 | Sale | −1,704 | $32.46 | $55,320 | 1,509 | D |
| FRATES JAMES M Chief Financial Officer | 2023-03-16 | Grant or award | +21,667 | 23,176 | D | ||
| Derivatives | |||||||
| FRATES JAMES M Chief Financial Officer | 2023-03-16 | Grant or award · Stock Option (right to buy) | +97,500 | 97,500 | D | ||
| Open-market sales · 32,500 sh · avg $31.89 · $1,036,459 | |||||||
Loading xslF345X04/doc4.xml…